Diamyd Medical AB (publ): Diamyd Medical announces finalization of database for interim analysis in Phase 3 DIAGNODE-3 trial

The clinical database has been finalized for the pre-specified interim efficacy analysis in Diamyd Medical's ongoing pivotal Phase 3 trial (DIAGNODE-3) evaluating retogatein (rhGAD65) in individuals w ...

Veru outlines new Phase IIb obesity trial and targets interim analysis in Q1 2027 while increasing cash reserves

Q1 2026 Management View CEO Mitchell Steiner stated that Veru is advancing its late-stage clinical pipeline, focusing on two oral small molecule drugs: enobosarm, a selective androgen receptor ...
ascopubs.org

Updated analysis from a phase 2 study of tislelizumab (TIS) monotherapy in patients (pts) with previously treated, locally advanced, unresectable/metastatic microsatellite ...

Patient-reported outcomes: The anal cancer patient lived experience. This is an ASCO Meeting Abstract from the 2022 ASCO Gastrointestinal Cancers Symposium. This abstract does not include a full text ...
ascopubs.org

EV-302: Updated analysis from the phase 3 global study of enfortumab vedotin in combination with pembrolizumab (EV+P) vs chemotherapy (chemo) in previously untreated locally ...

Neoadjuvant treatment with disitamab vedotin plus perioperative toripalimab in patients with muscle-invasive bladder cancer (MIBC) with HER2 expression: Updated efficacy and safety results from the ...
iaea.org

Analysis Phase of Systematic Approach to Training (SAT) for Nuclear Plant Personnel

The intention of this publication is to provide Member States with examples of the analysis phase to form the foundation of SAT-based training programmes. Although methods of analysis vary, the ...